
BillionToOne
Founded Year
2016Stage
Debt | AliveTotal Raised
$563.64MValuation
$0000Last Raised
$140M | 10 mos agoRevenue
$0000About BillionToOne
BillionToOne focuses on the prenatal and oncology sectors. The company provides molecular diagnostics services that detect and quantify disease-related deoxyribonucleic acid (DNA) fragments at a single base-pair level. BillionToOne serves the healthcare industry with an emphasis on prenatal screening and cancer therapy monitoring. It was founded in 2016 and is based in Menlo Park, California.
Loading...
Loading...
Research containing BillionToOne
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned BillionToOne in 1 CB Insights research brief, most recently on Dec 5, 2023.
Expert Collections containing BillionToOne
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
BillionToOne is included in 3 Expert Collections, including Digital Health.
Digital Health
11,408 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Women's Health Tech
711 items
This collection includes companies applying technology to address a spectrum of physical, mental, and social well-being concerns specific to women. Examples include companies in reproductive health, maternal care, fertility tracking, and menopause support.
Digital Health 50
50 items
BillionToOne Patents
BillionToOne has filed 16 patents.
The 3 most popular patent topics include:
- molecular biology
- genetics
- biotechnology

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
8/1/2022 | 12/31/2024 | Molecular biology, Biotechnology, Drug discovery, DNA sequencing, DNA | Grant |
Application Date | 8/1/2022 |
---|---|
Grant Date | 12/31/2024 |
Title | |
Related Topics | Molecular biology, Biotechnology, Drug discovery, DNA sequencing, DNA |
Status | Grant |
Latest BillionToOne News
May 22, 2025
(May 22, 2025) Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. Image: SpotitEarly PHASE Scientific secures $34M to advance urine-based women’s health diagnostics. Maternal and NICU care management company ProgenyHealth secures strategic investment to fund expansion. WeightWatchers files for bankruptcy amid diet drug growth and changing consumer preferences. Major US hospitals adopt DeepLook Medical‘s AI platform for breast cancer detection. Merck’s immunotherapy shows survival benefit in platinum-resistant ovarian cancer trial. BilliontoOne expands its prenatal test to screen for 14 genetic conditions from single maternal blood sample. Landmark study by Clue, MIT and University of Colorado links air pollution to menstrual cycle irregularities. Major endometriosis research institute established at UNSW Sydney with historic $50M donation . This week’s newsletter is sponsored by Flex: 🌟 Women’s Health Month with Flex: Turning Pre-Tax Dollars Into Growth for Women’s Health Brands In celebration of Women’s Health Month, Flex is raising awareness and helping women’s health brands unlock new revenue through pre-tax HSA/FSA spending. Flex enables e-commerce businesses to accept Health Savings Account (HSA) and Flexible Spending Account (FSA) payments—accessing $150B+ in pre-tax dollars for eligible health products. From menstrual care and fertility to postpartum recovery and menopause, Flex boosts conversion and removes friction at checkout. Take Embr, for example. Their wearable, the Embr Wave, helps manage hot flashes and other menopause symptoms. By enabling HSA/FSA payments through Flex, Embr has reached more customers who prefer to use pre-tax dollars. “HSA/FSA has become a key growth channel. Since partnering with Flex, we’ve exceeded six figures in FSA sales and seen double-digit growth,” said Sam Shames, Co-Founder and CRO of Embr. “It aligns with our mission to provide accessible, effective support for women’s health.” Interested in unlocking HSA/FSA for your business? 👇 In the Know Open Innovation: How Panasonic Well’s $1M Family Wellness Challenge Created Value for Startups and Corporate ( Femtech Insider ) How Climate Change Is Impacting People’s Ability to Have Healthy Pregnancies ( Time ) Women’s health is under attack – protecting it is the smart investment for everyone ( The Telegraph ) New Guidelines Call on Doctors to Take IUD Insertion Pain Seriously ( The New York Times ) Could this be the end of menopause as we know it? ( National Geographic ) Should companies offer period leave? ( Sifted ) Can TikTok Turn Doomscrolling Teens Into Meditators? ( Athletech News ) The longevity gap between men and women is getting bigger. Here’s why ( GQ ) ‘I wasn’t me any more’ – a photographer tackles her postnatal depression ( BBC ) Who’s Hiring?
BillionToOne Frequently Asked Questions (FAQ)
When was BillionToOne founded?
BillionToOne was founded in 2016.
Where is BillionToOne's headquarters?
BillionToOne's headquarters is located at 1035 O'Brien Drive, Menlo Park.
What is BillionToOne's latest funding round?
BillionToOne's latest funding round is Debt.
How much did BillionToOne raise?
BillionToOne raised a total of $563.64M.
Who are the investors of BillionToOne?
Investors of BillionToOne include Oberland Capital, Neotribe Ventures, Libertus Capital, Hummingbird Ventures, Fifty Years and 21 more.
Loading...
Loading...